Efficacy of transjugular intrahepatic portosystemic shunts in treating cirrhotic esophageal-gastric variceal bleeding

Table 1 Comparison of general data between the two groups [n (%), (mean ± SD)]

Item		Study group (n = 50)	Control group (n = 42)	Z/t/χ2	P value
Gender	Male	29 (58.00)	26 (61.90)	0.145	0.704
	Female	21 (42.00)	16 (38.10)
Age (years)		54.62 ± 7.17	55.18 ± 6.95	0.378	0.706
Etiology of liver cirrhosis	Viral hepatitis	28 (56.00)	23 (54.76)	0.000	0.989
	Alcoholic hepatitis	15 (30.00)	14 (33.33)
	Other	7 (14.00)	5 (11.90)

Table 2 Comparison of variceal status between the two groups [n (%)]

Item		Study group (n = 50)	Control group (n = 42)	Z	P value
Prior to surgery	Absence	0 (0.00)	0 (0.00)	0.533	0.465
	Mild	9 (18.00)	5 (11.90)
	Moderate	20 (40.00)	17 (40.48)
	Severe	21 (42.00)	20 (47.62)
One month postoperatively	Absence	19 (38.00)	4 (9.52)	5.269	0.022
	Mild	16 (32.00)	21 (50.00)
	Moderate	9 (18.00)	10 (23.81)
	Severe	6 (12.00)a	7 (16.67)a

^aP < 0.05 compared to preoperative values.

Table 3 Comparison of hemodynamics between the two groups (mean ± SD)

Item		Study group (n = 50)	Control group (n = 42)	t	P value
PVV (cm/s)	Preoperatively	13.42 ± 3.05	13.86 ± 3.17	0.677	0.500
	Postoperatively	43.28 ± 9.61a	37.81 ± 7.14a	3.048	0.003
PVD (cm)	Preoperatively	1.55 ± 0.30	1.53 ± 0.31	0.314	0.755
	Postoperatively	1.21 ± 0.23a	1.34 ± 0.26a	2.544	0.013

^aP < 0.05 compared to preoperative values.

PVV: Portal vein flow velocity; PVD: Portal vein diameter.

Table 4 Comparison of serum parameters between the two groups (mean ± SD)

Item		Study group (n = 50)	Control group (n = 42)	t	P value
PLT (× 109/L)	Preoperatively	84.37 ± 16.38	85.19 ± 15.92	0.242	0.809
	Postoperatively	134.17 ± 22.35a	115.64 ± 19.15a	4.225	0.001
RBC (× 1012/L)	Preoperatively	3.21 ± 0.72	3.18 ± 0.73	0.198	0.844
	Postoperatively	3.31 ± 0.65	3.29 ± 0.67	0.145	0.885
WBC (× 109/L)	Preoperatively	4.41 ± 0.75	4.39 ± 0.76	0.127	0.900
	Postoperatively	5.54 ± 0.92a	5.08 ± 0.86a	2.461	0.016

^aP < 0.05 compared to preoperative values.

PLT: Platelet count; RBC: Red blood cell count; WBC: White blood cell count.

Table 5 Comparison of liver function between the two groups (mean ± SD)

Item		Study group (n = 50)	Control group (n = 42)	t	P value
ALB (g/L)	Preoperatively	30.75 ± 6.24	31.29 ± 5.37	0.440	0.661
	Postoperatively	32.41 ± 4.96 ns	33.74 ± 6.62 ns	1.100	0.274
TBIL (μmol/L)	Preoperatively	33.16 ± 8.05	31.86 ± 6.92	0.822	0.413
	Postoperatively	34.81 ± 7.79 ns	33.01 ± 8.11 ns	1.083	0.282
AST (U/L)	Preoperatively	76.49 ± 7.17	77.28 ± 7.02	0.531	0.596
	Postoperatively	75.39 ± 9.81 ns	74.47 ± 8.25 ns	0.481	0.632

ns: P > 0.05 compared to preoperative levels.

ALB: Albumin; TBIL: Total bilirubin; AST: Aspartate transaminase.

Table 6 Comparison of quality of life between the two groups (mean ± SD)

Item		Study group (n = 50)	Control group (n = 42)	t	P value
Social function	Preoperatively	49.89 ± 4.17	49.92 ± 4.35	0.034	0.973
	Postoperatively	78.36 ± 3.81a	75.50 ± 3.66a	3.651	< 0.001
Psychological function	Preoperatively	48.30 ± 5.07	48.85 ± 4.96	0.523	0.602
	Postoperatively	70.16 ± 5.83a	65.28 ± 5.19a	4.203	< 0.001
Physical function	Preoperatively	45.69 ± 6.58	46.41 ± 6.75	0.517	0.607
	Postoperatively	65.25 ± 7.39a	60.67 ± 6.98a	3.037	0.003
Material life condition	Preoperatively	46.29 ± 5.11	46.57 ± 5.13	0.261	0.794
	Postoperatively	63.81 ± 6.78a	60.62 ± 5.75a	2.407	0.018

^aP < 0.05 compared to preoperative values.

Table 7 Comparison of re-bleeding and survival rates between the two groups [n (%)]

Item	Study group (n = 50)	Control group (n = 42)	χ2	P value
Re-bleeding rate	11 (22.00)	18 (42.86)	4.600	0.032
Survival rate	31 (62.00)	22 (52.38)	0.865	0.352